Riskpilot← Back to searchSign inGet full accessMedsharp AB
ABActiveOrg 5591526529Rödabergsgatan 12Computer consultancy and computer facilities management activities · NACE 6220Est. 20183 employees
Revenue 2024
SEK 6,3M
-8% vs 2023
EBITDA margin
29.9%
-17% vs 2023
Equity ratio
67.8%
Financial strength
Net profit 2024
SEK 1,6M
-14% vs 2023
| Revenue | SEK 6,3M | -8% |
| EBITDA | SEK 1,9M | -17% |
| Net profit | SEK 1,6M | -14% |
| Total assets | SEK 3,5M | +23% |
| Equity | SEK 2,4M | +4% |
| Employees | 3 | — |
Legal name
Medsharp AB
Org number
5591526529
Legal form
Aktiebolag
NACE code
6220 · Computer consultancy and computer facilities management activities
Founded
15 mars 2018
Share capital
SEK 50 000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Utveckla och supporta IT-system för hälso- och sjukvården i Sverige.
Address
Rödabergsgatan 12
Email
maria@medsharp.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 4 355 | 5 115 | 5 220 | 6 877 | 6 329 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 1 192 | 1 067 | 672 | 2 288 | 1 894 |
| Depreciation & amort. | −23 | −18 | −4 | −4 | −0 |
| EBIT | 1 169 | 1 049 | 668 | 2 284 | 1 894 |
| Net financials | −1 | −2 | −1 | 57 | 115 |
| Profit before tax | 1 168 | 1 046 | 667 | 2 340 | 2 009 |
| Tax | −251 | −217 | −140 | −489 | −415 |
| Net profit | 917 | 829 | 527 | 1 851 | 1 594 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 734 | 1 703 | 2 183 | 2 860 | 3 532 |
| Equity | 1 065 | 1 174 | 1 201 | 2 302 | 2 396 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 669 | 529 | 982 | 558 | 1 136 |
| Total debt | 669 | 529 | 982 | 558 | 1 136 |
EBITDA margin
29.9%
This company
15.8%
Market median
+89% vs market
20202024
Equity ratio
67.8%
This company
38.2%
Market median
+77% vs market
20202024
Return on equity
66.5%
This company
18.4%
Market median
+261% vs market
20202024
Net profit margin
25.2%
This company
8.1%
Market median
+211% vs market
20202024
Asset turnover
1.79×
This company
1.12×
Market median
+60% vs market
20202024
Debt / equity
0.47×
This company
0.62×
Market median
+24% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
LM Audit | Audit | 2021 |
JS Chief Executive Officer | Chief Executive Officer | 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2021 | |
| Board of Directors | 2021 | |
| Chairman | 2021 | |
| Board of Directors | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Medsharp AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Mattias Eklöf | Audit | 0 companies |
| Jan Stefan Solbrand | Chief Executive Officer | 0 companies |
| Bernt Evert Westlund | Board of Directors | 0 companies |
| Jenny Maria Andersson | Board of Directors | 0 companies |
| Jan Erik Olof Möller | Chairman | 0 companies |
| Lars Staffan Theodor Arvidson | Board of Directors | 0 companies |